| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.084 | 0.6 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |